RPPA: Origins, Transition to a Validated Clinical Research Tool, and Next Generations of the Technology

Emanuel Petricoin, Julie Wulfkuhle, Marissa Howard, Marielena Pierobon, Virginia Espina, Alessandra Luchini, Lance A. Liotta*

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

12 Scopus citations

Abstract

RPPA technology has graduated from a research tool to an essential component of clinical drug discovery research and personalized medicine. Next generations of RPPA technology will be a single clinical instrument that integrates all the steps of the workflow.

Original languageEnglish
Title of host publicationAdvances in Experimental Medicine and Biology
PublisherSpringer
Pages1-19
Number of pages19
DOIs
StatePublished - 2019
Externally publishedYes

Publication series

NameAdvances in Experimental Medicine and Biology
Volume1188
ISSN (Print)0065-2598
ISSN (Electronic)2214-8019

Keywords

  • Biomarkers
  • Drug discovery
  • Integrative genomics
  • RPPA
  • Reverse-phase protein array
  • Technology

Fingerprint

Dive into the research topics of 'RPPA: Origins, Transition to a Validated Clinical Research Tool, and Next Generations of the Technology'. Together they form a unique fingerprint.

Cite this